# Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

> **NCT03889886** · PHASE2 · COMPLETED · sponsor: **Silk Technologies, Ltd.** · enrollment: 305 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** SDP-4 Ophthalmic Solution (0.1%)
- **DRUG:** SDP-4 Ophthalmic Solution (1.0%)
- **DRUG:** SDP-4 Ophthalmic Solution (3.0%)
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03889886
- **Lead sponsor:** Silk Technologies, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-16
- **Primary completion:** 2019-10-07
- **Final completion:** 2019-10-11
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03889886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03889886, "Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03889886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*